MYELOSUPPRESSION
Clinical trials for MYELOSUPPRESSION explained in plain language.
Never miss a new study
Get alerted when new MYELOSUPPRESSION trials appear
Sign up with your email to follow new studies for MYELOSUPPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo shields bone marrow in tough lung cancer cases
Disease control Recruiting nowThis study tests whether giving a bone marrow-protecting drug (trilaciclib) before chemotherapy (sacituzumab tirumotecan) can reduce serious side effects like low white blood cell counts in people with advanced EGFR-mutant lung cancer that stopped responding to prior treatments. …
Matched conditions: MYELOSUPPRESSION
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated May 26, 2026 05:40 UTC
-
New drug aims to protect cancer patients from chemo side effect
Disease control Recruiting nowThis study tests whether mecapegfilgrastim can safely prevent moderate-to-severe low blood cell counts (myelosuppression) caused by chemotherapy and radiation in people with lung or esophageal cancer. About 30 adults aged 18-75 will receive the drug and be monitored for side effe…
Matched conditions: MYELOSUPPRESSION
Phase: PHASE2 • Sponsor: Affiliated Hospital of Nantong University • Aim: Disease control
Last updated May 26, 2026 04:38 UTC